Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Endocrinology

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE.0.1780319PMID 12904179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Estrogen Receptor-&agr; Mediates the Protective Effects of Estrogen Against Vascular Injury

  2002cited by this paper
• Estrogen Activates Phosphatases and Antagonizes Growth-Promoting Effect of Angiotensin II

  2002cited by this paper
• Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse.

  2002cited by this paper
• The protective effects of estrogen on the cardiovascular system.

  2002cited by this paper
• Inhibition of MEK1,2/ERK mitogenic pathway by estrogen with antiproliferative properties in rat aortic smooth muscle cells.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells*

  2001cited by this paper
• 17Beta-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism.

  2001cited by this paper
• Retinoids Inhibit Proliferation of Human Coronary Smooth Muscle Cells by Modulating Cell Cycle Regulators

  2001influential reference
• Mechanisms of Telomerase Induction During Vascular Smooth Muscle Cell Proliferation

  2001cited by this paper
• Induction of Endothelial Nitric-oxide Synthase Phosphorylation by the Raloxifene Analog LY117018 Is Differentially Mediated by Akt and Extracellular Signal-regulated Protein Kinase in Vascular Endothelial Cells*

  2001cited by this paper
• PI3‐kinase in concert with Src promotes the S‐phase entry of oestradiol‐stimulated MCF‐7 cells

  2001cited by this paper
• 17Beta-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism.

  2001cited by this paper
• Activation of Estrogen Receptor Blocks Interleukin-6-inducible Cell Growth of Human Multiple Myeloma Involving Molecular Cross-talk between Estrogen Receptor and STAT3 Mediated by Co-regulator PIAS3*

  2001cited by this paper
• p21 Is an Assembly Factor Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation*

  2000cited by this paper
• HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.

  2000cited by this paper
• p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

  2000cited by this paper
• Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation.

  2000cited by this paper
• Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells.

  2000cited by this paper
• Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

  2000cited by this paper
• Estrogen Receptors α and β Prevalence of Estrogen Receptor β mRNA in Human Vascular Smooth Muscle and Transcriptional Effects

  2000cited by this paper
• Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells.

  2000influential reference
• Estrogen Signals to the Preservation of Endothelial Cell Form and Function*

  2000cited by this paper
• Membrane Estrogen Receptor Engagement Activates Endothelial Nitric Oxide Synthase via the PI3-Kinase–Akt Pathway in Human Endothelial Cells

  2000cited by this paper
• Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects.

  2000cited by this paper
• Inhibition of Vascular Smooth Muscle Cell Proliferation by Sodium Salicylate Mediated by Upregulation of p21Waf1 and p27Kip1

  2000influential reference
• Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity.

  2000cited by this paper
• p21Waf1/Cip1 Is an Assembly Factor Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation*

  2000cited by this paper
• Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells.

  1999cited by this paper
• The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

  1999cited by this paper
• Cell cycle progression: new therapeutic target for vascular proliferative disease.

  1998cited by this paper
• Environmental estrogenic pollutants induce acute vascular relaxation by inhibiting L‐type Ca2+ channels in smooth muscle cells

  1998cited by this paper
• Anti-estrogens induce apoptosis of multiple myeloma cells.

  1998cited by this paper
• Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells.

  1998cited by this paper
• Hypoxic responses of vascular cells.

  1998cited by this paper
• Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice.

  1997cited by this paper
• E2F and the molecular mechanisms of early cell-cycle control.

  1996cited by this paper
• Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1

  1996cited by this paper
• 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males.

  1996cited by this paper
• MAP kinase does not inactivate, but rather prevents the cyclin degradation pathway from being turned on in Xenopus egg extracts.

  1996cited by this paper
• Proliferative response of smooth muscle cells after experimental balloon angioplasty.

  1996cited by this paper
• Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.

  1996cited by this paper
• Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway*

  1996cited by this paper
• Platelet-derived Growth Factor Stimulates Protein Kinase A through a Mitogen-activated Protein Kinase-dependent Pathway in Human Arterial Smooth Muscle Cells (*)

  1996cited by this paper
• 17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males

  1996cited by this paper
• Effects of 17 beta-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro.

  1996cited by this paper
• Induction of calcium-dependent nitric oxide synthase by sex hormones in the guinea-pig urinary bladder.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Estrogen inhibits the response-to-injury in a mouse carotid artery model.

  1995cited by this paper
• The Intima: Soil for Atherosclerosis and Restenosis

  1995cited by this paper
• Cell biology of atherosclerosis.

  1995cited by this paper
• Induction of calcium-dependent nitric oxide synthases by sex hormones.

  1994cited by this paper
• Platelet-derived growth factor receptor signals.

  1994cited by this paper
• Hormonal treatment of postmenopausal women.

  1994cited by this paper
• Acute Vascular Effects of Estrogen in Postmenopausal Women

  1994cited by this paper
• The L-arginine-nitric oxide pathway.

  1993cited by this paper
• Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease.

  1993cited by this paper
• Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries.

  1992cited by this paper
• E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

  1992influential reference
• Nuclear localization and regulation of erk- and rsk-encoded protein kinases

  1992cited by this paper
• Signal transduction within the nucleus by mitogen-activated protein kinase.

  1992cited by this paper
• Effects of estrogen on vein grafts.

  1992cited by this paper
• A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.

  1991cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

  1991cited by this paper
• Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro

  1991cited by this paper
• Estrogen modulates responses of atherosclerotic coronary arteries.

  1990cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper

• Evaluating the shared risk factors between atherosclerotic cardiovascular disease and cancer: how significant is the link?

  2025cites this paper
• Estradiol Downregulates MicroRNA-193a to Mediate Its Anti-Mitogenic Actions on Human Coronary Artery Smooth Muscle Cell Growth

  2025cites this paper
• Comprehensive profiling of RNA modification-related genes identifies RNA m7G binding protein CBP20 as a therapeutic target for tumor growth inhibition

  2025cites this paper
• Revealing the Landscape Crosstalk Between Reproductive System and Organs Aging

  2025cites this paper
• Estrogen Inhibits the Phenotypic Switching of Vascular Smooth Muscle Cells through ER-α/CREB in Aortic Dissection

  2025cites this paper
• Hormonal influence: unraveling the impact of sex hormones on vascular smooth muscle cells

  2024cites this paper
• Sex-dependent vascular effects of cadmium sub-chronic exposure on rats

  2022cites this paper
• The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation

  2018cites this paper
• Estrogen in vascular smooth muscle cells: A friend or a foe?

  2018cites this paper
• Effects of 17β-estradioland raloxifene on endothelial OPG and RANKL secretion.

  2017influential citation
• GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer

  2017cites this paper
• The role of sex steroid hormones in the pathophysiology and treatment of sarcopenia

  2016cites this paper
• Estrogens and Coronary Artery Disease: New Clinical Perspectives.

  2016cites this paper
• MicroRNAs Contribute to the Protective Actions of 17β-Estradiol on the Vascular System

  2016cites this paper
• Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors.

  2015cites this paper
• Estrogen and the female heart.

  2014cites this paper
• Sex hormones in the cardiovascular system

  2014cites this paper
• G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.

  2014cites this paper
• The anti-tumor activity of Antrodia salmonea in human promyelocytic leukemia (HL-60) cells is mediated via the induction of G₁ cell-cycle arrest and apoptosis in vitro or in vivo.

  2014cites this paper
• Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation

  2013cites this paper
• GPER: a novel target for non-genomic estrogen action in the cardiovascular system.

  2013cites this paper
• Estrogen and the cardiovascular system.

  2012influential citation
• Wpływ raloksyfenu na czynniki ryzyka kalcyfikacji naczyń

  2012cites this paper
• The theory of modulated hormone therapy for the treatment of breast cancer in pre- and post-menopausal women

  2012cites this paper
• The mechanism of vascular calcification – a systematic review

  2012influential citation
• Hormonal effects on blood vessels

  2012cites this paper
• Estrogens and atherosclerosis: insights from animal models and cell systems.

  2012cites this paper
• Interaction of Hydrogen Sulfide and Estrogen on the Proliferation of Vascular Smooth Muscle Cells

  2012influential citation
• Vasoprotective activity of standardized Achillea millefolium extract.

  2011cites this paper
• The G-protein-coupled estrogen receptor GPER in health and disease

  2011cites this paper
• Differential Regulation of the Inducible Nitric Oxide Synthase Gene by Estrogen Receptors α and β

  2010cites this paper
• Safety of pharmacotherapy of osteoporosis in cardiology patients.

  2010cites this paper
• A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells.

  2009cites this paper
• Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities.

  2009cites this paper
• Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2.

  2008cites this paper
• APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

  2008cites this paper
• STROGEN INDUCES RAPID TRANSLOCATION OF ESTROGEN ECEPTOR , BUT NOT ESTROGEN RECEPTOR , TO THE EURONAL PLASMA MEMBRANE

  2008cites this paper
• Synergistische Effekte des spezifischen COX-2-Inhibitors Celecoxib und des SERM Ly 117018 auf Mammakarzinomzellen in vitro

  2008cites this paper
• Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.

  2007cites this paper
• Selective estrogen receptor modulators and risk for coronary heart disease

  2007cites this paper
• The risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators.

  2007cites this paper
• RALOXIFENE, TAMOXIFEN AND VASCULAR TONE

  2007influential citation
• 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen

  2007cites this paper
• Estrogens and SERMs in coronary heart disease.

  2007cites this paper
• Estrogen accelerates G1 to S phase transition and induces a G2/M phase-predominant apoptosis in synthetic vascular smooth muscle cells.

  2007cites this paper
• Raloxifene increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1.

  2007cites this paper
• Raloxifene: cardiovascular considerations.

  2007cites this paper
• Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation

  2007cites this paper
• Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells.

  2007cites this paper
• 5-HT Induction of c-fos gene expression requires reactive oxygen species and rac1 and ras GTPases

  2007cites this paper
• Raloxifene Elicits Combined Rapid Vasorelaxation and Long-Term Anti-Inflammatory Actions in Rat Aorta

  2006cites this paper
• A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?

  2006cites this paper
• Effects of raloxifene on caveolin-1 mRNA and protein expressions in vascular smooth muscle cells.

  2006cites this paper
• Effects of selective estrogen receptor modulator raloxifene plus 17-beta estradiol in aorta and mammary gland of female experimental atherosclerosis rabbits and possible involvement of ERK signal transduction pathway.

  2006cites this paper
• Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells*

  2006cites this paper
• Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor &agr;

  2006cites this paper
• Selective Agonists of Estrogen Receptor Isoforms: New Perspectives for Cardiovascular Disease

  2006cites this paper
• Cardiovascular Disease and SERMs

  2006cites this paper
• TERM ANTI-INFLAMMATORY ACTIONS IN RAT AORTA

  2006cites this paper
• Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women.

  2005cites this paper
• Molecular mechanism of action of selective estrogen receptor modulator in target tissues.

  2005cites this paper
• Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells.

  2005cites this paper
• Actions of nitric oxide , estrogen , platelet activating factor and vasopressin on cardiovascular defense in rats

  2005cites this paper
• Effect of raloxifene on aortic elasticity in healthy postmenopausal women.

  2005cites this paper
• Proteasome-dependent degradation of ERalpha but not ERbeta in cultured mouse aorta smooth muscle cells.

  2004cites this paper
• Vascular biology of estrogen receptors alpha and beta : -An experimental approach to restenosis and transplant arteriosclerosis

  2004cites this paper
• Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo.

  2004cites this paper
• Endothelial function in isolated small arteries from women at reproductive age and after menopause - possibilities for improvement

  2003cites this paper